XML 18 R5.htm IDEA: XBRL DOCUMENT v3.24.2
CONDENSED CONSOLIDATED STATEMENTS OF EQUITY - USD ($)
$ in Thousands
Common stock
Treasury stock
Additional paid-in capital
Accumulated (deficit) earnings
Accumulated other comprehensive income (loss)
Noncontrolling interest
Total
Beginning of period at Dec. 31, 2022 $ 2 $ (385,010) $ 611,872 $ 20,723 $ 236 $ 1,169  
Repurchases of common stock   (78,728)          
Net income (loss)       10,875     $ 10,875
Dividends declared and paid ($0.05 and $0.045 per share of common stock in Q2 2024 and Q2 2023, respectively)       (13,460)      
Shares issued for stock options exercised     1,253        
Agent growth incentive stock compensation     17,903        
Agent equity stock compensation     65,652        
Stock option compensation     5,126        
Foreign currency translation gain (loss)         707   707
Ending of period at Jun. 30, 2023 2 (463,738) 701,806 18,138 943 1,169 258,320
Beginning of period at Mar. 31, 2023 2 (414,926) 650,383 15,580 879 1,169  
Repurchases of common stock   (48,812)          
Net income (loss)       9,422     9,422
Dividends declared and paid ($0.05 and $0.045 per share of common stock in Q2 2024 and Q2 2023, respectively)       (6,864)      
Shares issued for stock options exercised     946        
Agent growth incentive stock compensation     9,236        
Agent equity stock compensation     38,876        
Stock option compensation     2,365        
Foreign currency translation gain (loss)         64   64
Ending of period at Jun. 30, 2023 2 (463,738) 701,806 18,138 943 1,169 258,320
Beginning of period at Dec. 31, 2023 2 (545,559) 804,833 (16,769) 332 1,169 244,008
Repurchases of common stock   (81,266)          
Net income (loss)       (3,256)     (3,256)
Dividends declared and paid ($0.05 and $0.045 per share of common stock in Q2 2024 and Q2 2023, respectively)       (15,075)      
Shares issued for stock options exercised     1,052        
Agent growth incentive stock compensation     17,403        
Agent equity stock compensation     56,456        
Stock option compensation     3,960        
Foreign currency translation gain (loss)         (1,787)   (1,787)
Transactions with noncontrolling interests           $ (1,169)  
Ending of period at Jun. 30, 2024 2 (626,825) 883,704 (35,100) (1,455)   220,326
Beginning of period at Mar. 31, 2024 2 (578,591) 841,576 (39,993) (557)    
Repurchases of common stock   (48,234)          
Net income (loss)       12,383     12,383
Dividends declared and paid ($0.05 and $0.045 per share of common stock in Q2 2024 and Q2 2023, respectively)       (7,490)      
Shares issued for stock options exercised     75        
Agent growth incentive stock compensation     9,495        
Agent equity stock compensation     30,588        
Stock option compensation     1,970        
Foreign currency translation gain (loss)         (898)   (898)
Ending of period at Jun. 30, 2024 $ 2 $ (626,825) $ 883,704 $ (35,100) $ (1,455)   $ 220,326